Glarivibart
Glarivibart is a humanized IgG1κ monoclonal antibody inhibitor targeting Respiratory syncytial virus (RSV) fusion F protein (RSV-F) . Glarivibart has significant antiviral activity. Glarivibart can be used for RSV infections research[1].
Product Specifications
CAS Number
[3033697-08-1]
UNSPSC
12352100
Target
RSV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items